Unknown

Dataset Information

0

Discovery of new liver X receptor agonists by pharmacophore modeling and shape-based virtual screening.


ABSTRACT: Agonists of liver X receptors (LXR) ? and ? are important regulators of cholesterol metabolism, but agonism of the LXR? subtype appears to cause hepatic lipogenesis, suggesting LXR?-selective activators are attractive new lipid lowering drugs. In this work, pharmacophore modeling and shape-based virtual screening were combined to predict new LXR?-selective ligands. Out of the 10 predicted compounds, three displayed significant LXR activity. Two activated both LXR subtypes. The third compound activated LXR? 1.8-fold over LXR?.

SUBMITTER: Temml V 

PROVIDER: S-EPMC3934620 | biostudies-literature | 2014 Feb

REPOSITORIES: biostudies-literature

altmetric image

Publications

Discovery of new liver X receptor agonists by pharmacophore modeling and shape-based virtual screening.

Temml Veronika V   Voss Constance V CV   Dirsch Verena M VM   Schuster Daniela D  

Journal of chemical information and modeling 20140206 2


Agonists of liver X receptors (LXR) α and β are important regulators of cholesterol metabolism, but agonism of the LXRα subtype appears to cause hepatic lipogenesis, suggesting LXRβ-selective activators are attractive new lipid lowering drugs. In this work, pharmacophore modeling and shape-based virtual screening were combined to predict new LXRβ-selective ligands. Out of the 10 predicted compounds, three displayed significant LXR activity. Two activated both LXR subtypes. The third compound act  ...[more]

Similar Datasets

| S-EPMC8693749 | biostudies-literature
| S-EPMC9400856 | biostudies-literature
| S-EPMC3858292 | biostudies-literature
| S-EPMC8695346 | biostudies-literature
| S-EPMC10695404 | biostudies-literature
| S-EPMC4025812 | biostudies-other
| S-EPMC3558715 | biostudies-literature
| S-EPMC10449137 | biostudies-literature
| S-EPMC4395532 | biostudies-literature
| S-EPMC4088285 | biostudies-literature